SCHEMBL1699265

SCHEMBL1699265

CCc1c(OCC(F)(F)F)cnc2c1[nH]c(=O)n2-c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
LMNA P02545 2/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAOB P27338 1/20 0.36
USP1 O94782 1/20 0.35
GRM2 Q14416 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699528 0.83 NPC1 (0.51) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699174 0.83 NPC1 (0.51) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699242 0.81 L3MBTL1 (0.56) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699258 0.78 L3MBTL1 (0.55) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699557 0.78 HDAC1 (0.37) MEN1KMT2AKDM4ERXFP1LMNA
SCHEMBL1699315 0.77 NPC1 (0.50) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699234 0.73 L3MBTL1 (0.54) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699310 0.73 NPC1 (0.59) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699185 0.72 NPC1 (0.50) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699299 0.70 NPC1 (0.45) NPC1RAB9AL3MBTL1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed